Meeting
2023 ASCO Genitourinary Cancers Symposium
Contemporary use of wearable activity monitors in prostate cancer survivors: A scoping review.
Authors
Brandon Noorvash
Cedars-Sinai Medical Center, Los Angeles, CA
Brandon Noorvash , Carolina Raines , Edwin Melencio Posadas , Howard M. Sandler , Stephen J. Freedland , Gillian Gresham
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 127)
DOI
10.1200/JCO.2023.41.6_suppl.127
Abstract #
127
Poster Bd #
E12
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio).
First Author: Andrew Warren Hahn
Poster
2017 Cancer Survivorship Symposium
Exercise, metabolic syndrome, and cardiovascular fitness in breast cancer survivors.
First Author: M. Tish Knobf
Poster
2014 ASCO Annual Meeting
Effect of 12-week home-based exercise program on fasting insulin in stage II-III colorectal cancer survivors: A randomized controlled trial.
First Author: MI KYUNG LEE
Poster
2024 ASCO Genitourinary Cancers Symposium
The “Get Moving Trial”: A phase I/II RCT of home-based (P)rehabilitation ((P)REHAB) with ExerciseRx in muscle-invasive bladder cancer (MIBC)—Study protocol for a randomized controlled trial.
First Author: Hanna Hunter